Overview An Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in Neonates Status: Completed Trial end date: 2007-10-01 Target enrollment: Participant gender: Summary This study will evaluate pharmacokinetics and safety of intravenous micafungin in neonates with suspected candida infection Phase: Phase 1 Details Lead Sponsor: Astellas Pharma IncTreatments: EchinocandinsMicafungin